{{Rsnum
|rsid=3087879
|Gene=SLC1A1
|Chromosome=9
|position=4586808
|Orientation=plus
|GMAF=0.2374
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=SLC1A1,SPATA6L
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 9.2 | 44.6 | 46.2
| HCB | 0.0 | 15.6 | 84.4
| JPT | 0.0 | 31.8 | 68.2
| YRI | 3.2 | 21.0 | 75.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 15.6 | 84.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19349310
|Title=A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder
|OA=1
}}

{{PMID Auto
|PMID=22665263
|Title=Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies
}}

{{PMID Auto
|PMID=19324536
|Title=Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder.
|OA=1
}}

{{PMID Auto
|PMID=22776887
|Title=Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}